Literature DB >> 24900598

Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2013        PMID： 24900598      PMCID： PMC4027247          DOI： 10.1021/ml400361q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Novel HDL-directed pharmacotherapeutic strategies.

Authors:  Emil M Degoma; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2011-01-18       Impact factor: 32.419

2.  Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo.

Authors:  Weijun Jin; John S Millar; Uli Broedl; Jane M Glick; Daniel J Rader
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 3.  The role of endothelial lipase in high-density lipoprotein metabolism.

Authors:  Karen O Badellino; Daniel J Rader
Journal:  Curr Opin Cardiol       Date:  2004-07       Impact factor: 2.161
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.